Biopid wins approval for atopic skin disease drug

A local biopharmaceutical company has won approval to produce a novel medicine for the topical treatment of atopic skin disease.

Biopid announced Tuesday that the Korea Food and Drug Administration approved its product Utoma solution after intensive studies of development.

Utoma induces the synthesis of Ceramide lipid by improving the symptoms associated with the hyper-ingestion of unsat...